Saffron: Mood Evidence, Forms & Safety

Saffron is associated with the red stigmas of Crocus sativus. Trials have tested particular capsules or extracts, while other research concerns isolated constituents such as crocin. A kitchen quantity of spice is not an established equivalent of a study product.^{See reference 2,See reference 5}

A supplement sold today may differ from the formulation used in a trial. The complete ingredient list, plant part and preparation are therefore more useful than assuming that every product labelled saffron has the same evidence.^{See reference 4}

The review included 34 trials and 1,769 adults. Beck Depression Inventory and Beck Anxiety Inventory scores improved on average, but results differed greatly between studies. The authors rated certainty as moderate and reported no significant effects for the Hamilton depression scale, Hamilton anxiety scale or Profile of Mood States.^{See reference 1}

Self-reported and clinician-rated findings should stay visible together. The review’s abstract does not settle every product, population or long-term question. No unseen full-text assessment of individual trial bias or funding is claimed here.^{See reference 1}

The six-week placebo-controlled pilot enrolled 40 adults with mild to moderate major depression and tested a particular saffron capsule. It reported a better Hamilton depression score than placebo. Its small size, single setting and short follow-up limit how far that finding can be applied.^{See reference 2}

A separate six-week pilot in 40 adults compared a stigma extract with fluoxetine and found no statistically significant between-group difference. Absence of a significant difference is not, by itself, proof that two treatments are equivalent. That is a statistical limit, not a personal medicine-switching recommendation.^{See reference 3}

The crocin safety study followed 44 healthy volunteers for one month. It found no major adverse events, while some measured laboratory parameters changed. It tested an isolated saffron constituent, not every whole-saffron product or a long-term mood treatment.^{See reference 5}

NCCIH advises checking supplements with a health professional, particularly when taking medicines or during pregnancy or breastfeeding. A natural origin does not ensure safety. The trials discussed here cannot provide an individual safety clearance or rule out interactions.^{See reference 4}

NCCIH advises against replacing prescribed medicine with a dietary supplement without discussing it with the treating clinician. This guide offers no dose, treatment plan or instruction to stop an antidepressant. Discuss the exact proposed product and the outcome you hope to improve.^{See reference 6}

Changes in a symptom questionnaire do not establish prevention of suicide, durable recovery, cognitive protection or longer life. Those outcomes are outside the studies summarized here and should not be added to a product claim.^{See reference 1,See reference 2}